Mixed Topics
News
Neutropenia affects clinical presentation of pulmonary mucormycosis
Bronchoalveolar lavage was s stronger contributor to diagnosis in nonneutropenic patients.
News
New global initiative aims to reform cancer trials and care
“One concern is that over the last 10 years or so, most of our new treatments have had very, very small benefits and we think the bar has dropped...
News
Cardiorespiratory fitness linked to cancer risk, mortality?
“The clinical implications of these findings further emphasize the importance of CRF for possibly reducing cancer incidence and mortality.”
News
ESMO helps hematologists assess new cancer drugs
The group’s new study evaluation tool, the ESMO-MCBS:H, is aimed at helping doctors and others determine the benefit of new blood cancer therapies...
Latest News
Harvard medical school sued over stolen body part scandal
The indictment alleges that from 2018 through August 2022, Harvard morgue manager Cedric Lodge stole dissected portions of donated cadavers,...
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
Conference Coverage
CMML: GM-CSF inhibitor lenzilumab shows early promise
The PREACH-M trial has yielded encouraging preliminary results in treating CMML, a rare, “insidious” leukemia that can transform into AML.
Conference Coverage
PV: Novel rusfertide shows ‘impressive’ efficacy
The novel synthetic form of liver hormone hepcidin represents a “paradigm shift” in polycythemia vera treatment, allowing patients to avoid the...
Conference Coverage
Cancer drug shortages spur worry, rationing, and tough choices
Limited supplies of crucial medications are disrupting patient care, oncologists say.
Conference Coverage
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
A pair of new studies show that drugs can reduce cancer risk when cells are elusive.
